NCT00788515View on ClinicalTrials.gov

Comparison of Volinanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties

PHASE3TerminatedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Sleep Initiation and Maintenance Disorders
Interventions
DRUG

Volinanserin (M100907)

2 mg tablets QD

DRUG

Lormetazepam

1 mg tablets (overencapsulated) QD

Trial Locations (3)

Unknown

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Barcelona

Sanofi-Aventis Administrative Office, Bromma

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY